Could a simple scan unlock better cancer treatment? new study tests targeted imaging
NCT ID NCT07554742
First seen Apr 29, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This study will test a new type of PET scan that looks for a protein called Claudin18.2 on cancer cells in people with pancreatic or stomach cancer. The goal is to see if this scan can accurately find which tumors have this protein, helping doctors choose the right targeted therapy. About 64 participants will be scanned before surgery, and their results will be compared to lab tests on the removed tumor tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.